Conference On Improving Security In Marseille's Central Districts Held - Marseille

Conference On Improving Security In Marseille's Central Districts Held - Marseille

(L to R): Nicolas Bessone (Marseille public prosecutor) and Frederique Camilleri (Bouches-du-Rhone police prefect) seen at a conference on improving security in Marseille's central districts held at the Noailles police station in Marseille, France on 16 January 2024. Photo by Laurent Coust/ABACAPRESS.COM.

  • Product Code
  • ILEA002192518
  • Registered date
  • 2024/1/16 00:00:00
  • Credit
  • Abaca Press / Kyodo News Images
  • Media source
  • Coust Laurent/ABACA
  • Media size
  • 7454 × 4969 pixel
  • Resolution
  • 300 dpi
  • Deployment size
  • 2.86(MB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    coust-doli

    coust-doli

    Illustration of Lysopaine boxe from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
      coust-doli

      coust-doli

      Illustration of Doliprane boxes from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
        coust-doli

        coust-doli

        Illustration of Doliprane boxes from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
          coust-doli

          coust-doli

          Illustration of Doliprane boxes from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
            coust-doli

            coust-doli

            Illustration of Doliprane tablet from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
              coust-doli

              coust-doli

              Illustration of Doliprane boxe from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
                coust-doli

                coust-doli

                Illustration of Doliprane boxe from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
                  coust-doli

                  coust-doli

                  Illustration of Doliprane boxes from the SANOFI Opella laboratory in Marseille, France on October 11, 2024. Sanofi's Doliprane to become American with CD&R's takeover of Opella. The French pharmaceutical group has confirmed that it is in exclusive negotiations with CD&R. The American fund is seeking to acquire its Opella subsidiary, which produces Doliprane. Photo by Coust Laurent/ABACAPRESS.COM
                    Clara Chappaz Visits Tangram, CMA CGM's Training Centre - Marseille

                    Clara Chappaz Visits Tangram, CMA CGM's Training Centre - Marseille

                    Rodolphe Saade in the offices of TANGRAM, CMA CGM's training centre, during the visit of Clara Chappaz (R), Secretary of State to the Minister for Higher Education and Research, responsible for Artificial Intelligence and Digital Technologies, in Marseille, France on 07 October 2024. Photo by Laurent Coust/ABACAPRESS.COM
                      Clara Chappaz Visits Tangram, CMA CGM's Training Centre - Marseille

                      Clara Chappaz Visits Tangram, CMA CGM's Training Centre - Marseille

                      Clara Chappaz, Secretary of State to the Minister for Higher Education and Research, in charge of Artificial Intelligence and Digital Technologies with Rodolphe Saade (L), visits the offices of TANGRAM, CMA CGM's training centre in Marseille, France on 07 October 2024. Photo by Laurent Coust/ABACAPRESS.COM